Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ABVC

ABVC BioPharma (ABVC)

ABVC BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABVC
DateTimeSourceHeadlineSymbolCompany
12/19/20247:30AMGlobeNewswire Inc.ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21NASDAQ:ABVCABVC BioPharma Inc
12/11/20245:30AMGlobeNewswire Inc.ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three PartnersNASDAQ:ABVCABVC BioPharma Inc
11/15/20242:31PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
11/15/20242:30PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
11/15/20242:28PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
11/15/20242:26PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
11/14/20246:33PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ABVCABVC BioPharma Inc
11/14/20248:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
11/14/20248:00AMGlobeNewswire Inc.ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational MilestonesNASDAQ:ABVCABVC BioPharma Inc
11/14/20247:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABVCABVC BioPharma Inc
11/04/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
10/25/202411:21AMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
10/22/20247:45AMGlobeNewswire Inc.ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic PartnersNASDAQ:ABVCABVC BioPharma Inc
10/18/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
09/10/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
08/20/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
08/16/20243:31PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
08/16/20243:30PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
08/16/20243:30PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
08/15/20246:30AMGlobeNewswire Inc.ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic AchievementsNASDAQ:ABVCABVC BioPharma Inc
08/15/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
08/14/20242:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABVCABVC BioPharma Inc
08/07/20244:15PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABVCABVC BioPharma Inc
08/01/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ABVCABVC BioPharma Inc
07/26/20243:30PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ABVCABVC BioPharma Inc
07/23/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
07/12/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
07/12/20243:00PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ABVCABVC BioPharma Inc
05/24/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
05/23/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABVC

Your Recent History

Delayed Upgrade Clock